Nina Moreno, Nelson Labs, explains how rapid sterility testing is reshaping pharmaceutical quality control—cutting release ...
The company’s new AI agent automates labor-intensive processes involved in trial document management.
Saharsh Davuluri, Neuland Labs, urges API and peptide automation by 2026 to match modern biologics standards.
Rare diseases, defined by FDA as “a disease or condition that affects less than 200,000 people in the United States” (1), may ...
Paolo Ferrigno Product Manager prefilled syringes and cartridges Datwyler Healthcare ...
PharmTech recently spoke with Saharsh Davuluri, Vice Chairman and Managing Director, Neuland Labs, to get his perspective on trends that shaped pharmaceutical development and manufacturing in 2025 and ...
In Episode 31, industry veteran Deborah Dunsire goes behind the headlines to discuss the current state of innovation and ...
In this part 3 of our three-part interview, Stenberg explores the evolving manufacturing paradigm in the pharmaceutical ...
Laine Mello, director of marketing at Ecolab Bioprocessing, reflects on how the use of digital technologies expanded in the ...
Amgen is committed to reducing drug costs, expanding its AmgenNow program, and investing in US manufacturing to gain tariff ...
UKRI Innovate UK and NRC IRAP provide funding and advisory support, fostering UK-Canada collaboration in genetic medicine ...
PharmTech spoke with Ian Bilodeau, managing director, Ardena US about how the expanded use of AI has impacted the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback